Mitigating risk in the development of clinical antibodies The commercial development of therapeutic antibodies is not without its risks. Read More Bioinformatics, Biomedical Research, Business, Immunotherapy, Protein Engineering, Structural BiologyGordon WebsterJune 8, 2021antibodies, protein engineering, structural biology, bioinformatics, immunology, immunotherapy